Previously accumulated evidence shows that FXS-associated neurobiological changes are brain region-specific [36,37,38], and the hippocampus is among the brain regions that are affected by the loss of FMRP [39,40,41]. The gene discussed is FMR1; the disease is fragile X syndrome.